ArticleJournal of translational medicine2022

Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study.

Benjamin Van Tassell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.